Liquid Crystal Fatty Acid Esters for Selective Pathogen Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for intestinal disorders, particularly those caused by pathogenic bacteria like C. difficile, often harm beneficial flora due to non-selective action of antibiotics, leading to recurrence and resistance issues, and existing antimicrobial agents like glycerol monolaurate have solubility and stability problems.
Innovation Solution
A stable, highly soluble liquid crystal mixture of biologically active medium-chain fatty acid esters, such as polyglycerol monolaurin, is administered in conjunction with probiotics to inhibit pathogenic bacterial growth while promoting beneficial flora, using a polyhydric alcohol solvent and alkali reactants to enhance solubility and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If antibiotics are used to treat pathogenic bacteria, then harmful pathogens are killed, but beneficial microorganisms are also destroyed leading to impaired health and digestive function
Solution Approach 1:
The patent applies local quality by creating a fatty acid ester composition with specific properties (medium-chain triglycerides combined with alkali salts) that selectively targets pathogenic bacteria while sparing beneficial flora. The composition has tailored solubility and stability characteristics that enable localized action in the gastrointestinal tract, allowing differentiation between harmful and beneficial microorganisms based on their distinct physiological characteristics.
Solution Approach 2:
The patent utilizes parameter changes by modifying the chemical structure and properties of fatty acid esters to achieve selective antimicrobial activity. By adjusting the chain length, esterification degree, and salt formation parameters, the composition achieves optimal solubility and stability that enable selective inhibition of pathogenic bacteria without affecting beneficial microorganisms, thus resolving the non-selectivity problem of conventional antibiotics.
2Reliability
If conventional antibiotics are used, then bacterial infections are treated, but antibiotic-resistant pathogens develop and secondary opportunistic infections occur
Solution Approach 1:
The patent employs a naturally derived fatty acid ester composition that acts as a temporary, non-persistent antimicrobial agent. Unlike conventional antibiotics that can select for resistant strains through prolonged exposure, this composition provides effective treatment while being rapidly metabolized and eliminated, preventing the development of resistance. The natural origin and short duration of action make it ideal for avoiding secondary opportunistic infections.
3Object-affected harmful factors
If glycerol monolaurate is used as an antimicrobial agent, then pathogenic bacteria are inhibited, but solubility and stability problems occur
Solution Approach 1:
The patent creates a composite fatty acid ester composition by combining medium-chain triglycerides with alkali salts (such as sodium, potassium, calcium, or magnesium salts). This composite structure synergistically improves both solubility and stability while maintaining antimicrobial efficacy. The combination allows the composition to remain stable in various gastrointestinal conditions while achieving the desired inhibition of pathogenic bacteria, overcoming the limitations of pure glycerol monolaurate.
Data Source
AI summary
Compositions and methods for the treatment of intestinal infections. Compositions that include a liquid crystal mixture of an antimicrobial glycerol fatty acid ester and a polyhydric alcohol inhibit the growth of numerous deleterious intestinal pathogenic bacteria, including C. difficile. C. difficile is the causative agent in an increasing number of antibiotic-resistant bacterial infections. The formulations may be administered orally as capsules or soft gels, or alternatively as a enema, colonic, or rectal suppository. When combined with a probiotic supplement, the liquid crystal combinations reported here are able to treat an intestinal bacterial infection effectively and safely, thus promoting general intestinal health.